Home » New Drug Import Program Is Under Consideration
New Drug Import Program Is Under Consideration
The FDA will test a secure supply-chain pilot program for imported drugs and active pharmaceutical ingredients (APIs) to determine whether such a plan is practical. Companies participating in the pilot program would have a greater chance of gaining expedited entry for their imported finished drugs or APIs, according to a Thursday Federal Register notice.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May